News
YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar ...
5d
Indulgexpress on MSNStop relying on this common eye product to mask rednessOTC eye drops, especially those labelled “redness relief,” often contain vasoconstrictors. These refer to ingredients that shrink the blood vessels on the eye’s surface to reduce redness. While this ...
Active Biotech (NASDAQ STOCKHOLM: ACTI) today announced that the European Patent Office (EPO) has granted the patent application 21749566.2 related to tasquinimod in myelofibrosis ...
16h
AZ Animals on MSNCan Dogs Get Pink Eye, How Do You Treat It?Pink eye is a common condition among humans and is usually treated with eye drops in minor cases. But pink eye is also prevalent in the veterinary world, with dogs being susceptible to this ailment as ...
A new genomic test offered at Great Ormond Street Hospital (GOSH) has enabled Moorfields ophthalmologists to successfully treat a case of treatment-resistant uveitis.
Dr Jyothi RaghuramSenior Consultant - Pediatrics & Pediatric Rheumatology, Aster Whitefield Hospital, Bengaluru is ...
Eculizumab biosimilars could provide European patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic ...
BeiGene , Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that will change its name to BeOne Medicines Lt ...
TEVIMBRA is a uniquely designed humanized immunoglobulin G4 (IgG4) anti-programmed cell death protein 1 (PD-1) monoclonal antibody with high affinity and binding specificity against PD-1. It is ...
1. Vitamin D Vitamin D supplementation has been found to reduce symptoms of anxiety. However, it's not exactly clear how vitamin D helps ease anxiety symptoms. One study that included over ...
An Australian woman says that she spent a small fortune seeking treatment for painful symptoms, only to realize they were entirely self-inflicted. “If you ever feel embarrassed about anything ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results